Biography
Dr Yuanxin Xu (MD, PhD) is a clinician-scientist from Harbin Medical University, where she leads an integrated “Clinic → Mechanism → Clinic” research program focused on the molecular mechanisms of metabolic diseases and their cardiovascular complications. Her work combines big data analytics, multi-omics, and bioinformatics to advance precision medicine. Clinically, Dr Xu has managed over 6,000 patients with metabolic disorders and remains dedicated to translational research.
In 2024, Yuanxin joined A/Prof Jacob Qi’s research team, where her current work focuses on evaluating the cardioprotective effects of anti-diabetic medications.
Publications
Xu Y, Jiang YC, Xu L, Zhou W, Zhang Z, Qi Y, Kuang H, Yan S. Independent risk factors of left ventricular hypertrophy in non-diabetic individuals in Sierra Leone - a cross-sectional study. Lipids Health Dis. 2024 Aug 21;23(1):259. doi: 10.1186/s12944-024-02232-8. PMID: 39169399; PMCID: PMC11337744.
Xu Y, Chen J, Yang Z, Xu L. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs). Medical Science Monitor. 2019;25:1140-1154. Published 2019 Feb 12. doi:10.12659/MSM.912450
Wang Y, Zhou W, Liu D, Zhang Z, Xu Y, Wan X, Yu H, Yan S. Exploration of the molecular mechanism of insulin resistance in adipose tissue of patients with type 2 diabetes mellitus through a bioinformatic analysis. Minerva Endocrinol (Torino). 2023 Dec;48(4):440-446. doi: 10.23736/S2724-6507.22.03771-X. Epub 2023 Aug 3. PMID: 37534872.
Ren X, Du H, Cheng W, Wang Y, Xu Y, Yan S, Gao Y. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer. Front Endocrinol (Lausanne). 2022 Nov 4;13:997873. doi: 10.3389/fendo.2022.997873. PMID: 36407322; PMCID: PMC9672669.
Zhou W, Wang Y, Gao H, Jia Y, Xu Y, Wan X, Zhang Z, Yu H, Yan S. Identification of Key Genes Involved in Pancreatic Ductal Adenocarcinoma with Diabetes Mellitus Based on Gene Expression Profiling Analysis. Pathology Oncology Research. 2021 Apr 20;27:604730. doi: 10.3389/pore.2021.604730. PMID: 34257566; PMCID: PMC8262175.